Literature DB >> 30445185

Glucocorticoid signaling and osteoarthritis.

Olga Savvidou1, Mandy Milonaki2, Stavros Goumenos3, Dimitrios Flevas4, Panayiotis Papagelopoulos5, Paraskevi Moutsatsou6.   

Abstract

Glucocorticoids are steroid hormones synthesized and released by the adrenal cortex. Their main function is to maintain cell homeostasis through a variety of signaling pathways, responding to changes in an organism's environment or developmental status. Mimicking the actions of natural glucocorticoids, synthetic glucocorticoids have been recruited to treat many diseases that implicate glucocorticoid receptor signaling such as osteoarthritis. In osteoarthritis, synthetic glucocorticoids aim to alleviate inflammation and pain. The variation of patients' response and the possibility of complications associated with their long-term use have led to a need for a better understanding of glucocorticoid receptor signaling in osteoarthritis. In this review, we performed a literature search in the molecular pathways that link the osteoarthritic joint to the glucocorticoid receptor signaling. We hope that this information will advance research in the field and propose new molecular targets for the development of more optimized therapies for osteoarthritis.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Glucocorticoid; Homeostasis; Inflammation; Osteoarthritis; Receptor; Signaling

Mesh:

Substances:

Year:  2018        PMID: 30445185     DOI: 10.1016/j.mce.2018.11.001

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

Review 1.  A Jack of All Trades: Impact of Glucocorticoids on Cellular Cross-Talk in Osteoimmunology.

Authors:  Mubashir Ahmad; Yasmine Hachemi; Kevin Paxian; Florian Mengele; Mascha Koenen; Jan Tuckermann
Journal:  Front Immunol       Date:  2019-10-17       Impact factor: 7.561

2.  Dexamethasone-loaded thermo-sensitive hydrogel attenuates osteoarthritis by protecting cartilage and providing effective pain relief.

Authors:  Qi-Shan Wang; Bing-Xin Xu; Kai-Jian Fan; Yun-Shan Fan; Hui Teng; Ting-Yu Wang
Journal:  Ann Transl Med       Date:  2021-07

3.  Identification of Transcription Factors Responsible for a Transforming Growth Factor-β-Driven Hypertrophy-like Phenotype in Human Osteoarthritic Chondrocytes.

Authors:  Nathalie G M Thielen; Margot Neefjes; Elly L Vitters; Henk M van Beuningen; Arjen B Blom; Marije I Koenders; Peter L E M van Lent; Fons A J van de Loo; Esmeralda N Blaney Davidson; Arjan P M van Caam; Peter M van der Kraan
Journal:  Cells       Date:  2022-04-05       Impact factor: 6.600

4.  Identification of SCRG1 as a Potential Therapeutic Target for Human Synovial Inflammation.

Authors:  Guoqiang Liu; Guisong He; Jie Zhang; Zhongmin Zhang; Liang Wang
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

Review 5.  Recent advances in the treatment of osteoarthritis.

Authors:  Susanne Grässel; Dominique Muschter
Journal:  F1000Res       Date:  2020-05-04

6.  Identification of Novel Targets of Knee Osteoarthritis Shared by Cartilage and Synovial Tissue.

Authors:  Chenshuang Li; Zhong Zheng
Journal:  Int J Mol Sci       Date:  2020-08-22       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.